Center for U.S. Policy Welcomes Distinguished Leaders to Its Board of Directors
Ronne Ostby, M.A.; LaTonya Pinkard, M.Ed.; and Marsha Stanton, Ph.D., R.N., have been elected to CUSP's board of directors.
Consumers Must Make Informed Decisions Regarding Cannabinoids
The Center for U.S. Policy’s chairman publishes an opinion piece in CONQUER Magazine.
There Is Another Drug Reform Bill the Senate Must Pass
CUSP’s chairman urges the U.S. Senate to pass S.3257, a bill to remove an unnecessary barrier to treatment for opioid use disorder.
Journal Seeks Articles on Innovative Opioid Policies
The Journal of Opioid Management has issued a call for articles for its special issue on opioid law and policy. Submissions are due January 30, 2023.
Individual Stories Underlie Addiction
Center for U.S. Policy Senior Fellow Lynn R. Webster, M.D shares his opinion on the Hulu series Dopesick.
Statement on Supreme Court Decision in Ruan v. U.S.
Center for U.S. Policy praises the Supreme Court’s decision, saying it will improve access to medically necessary treatments.
The Supreme Court Is About To Affect Every Prescriber in America
A question of criminal liability under the Controlled Substances Act is before the U.S. Supreme Court.
New Resources Educate Decision Makers on Insurance Coverage of Rx Digital Therapies
Center for U.S. Policy to co-host webinar on the advantages of providing health insurance coverage of prescription digital therapies.
Federal Government Facilitates Access To Rx Digital Behavioral Therapies
Center for U.S. Policy praises the federal government for facilitating access to prescription digital behavioral therapies.
Collaboration Should Be Lauded, Not Denounced
Center for U.S. Policy Senior Fellow Lynn Webster, M.D. respond to article, “How Nonprofits Helped Fuel the Opioid Crisis.”